Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will determine the pharmacokinetics and safety of intravenous citrulline given to
children undergoing cardiopulmonary bypass for the correction of congenital heart defects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center